Samantha Schneider, MD
Dermatology · Carson City, NVNPI 1992190235
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 28.1% of the total. That places this record below the midpoint for dermatology clinicians in NV, where the typical reported total is $3,854.
Across 64 payments — averaging $22.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$400
- Pfizer$128
- Lilly USA, LLC$124
- Regeneron Healthcare Solutions, Inc.$120
- E.r. Squibb & Sons, L.L.C.$81
- Johnson & Johnson$73
- plus $497 from 12 others
What the payments were for
- Food & beverage$1,38397%
- Education$393%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $400 |
| Pfizer | 3 | $128 |
| Lilly USA, LLC | 6 | $124 |
| Regeneron Healthcare Solutions, Inc. | 4 | $120 |
| E.r. Squibb & Sons, L.L.C. | 4 | $81 |
| Johnson & Johnson | 4 | $73 |
| Organogenesis Inc. | 3 | $62 |
| Amgen | 3 | $57 |
| Sun Pharmaceutical Industries Inc. | 3 | $47 |
| Catalyst Orthoscience | 1 | $47 |
| UCB, Inc. | 3 | $46 |
| Biofrontera Inc. | 2 | $43 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $43 |
| Sweetbio, Inc. | 1 | $42 |
| Novartis | 2 | $40 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| Krystal Biotech Inc | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
How this compares
$1,423 in reported general payments places this provider in the 25th percentile of 78 dermatology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 15 | $580 |
| Fluocinonide | 18 | $500 |
| Ketoconazole | 21 | $467 |
| Triamcinolone Acetonide | 26 | $326 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Carson City
- David TackCarson City$4K
- Brianne MadsenCarson City$1K
- David CotterLas Vegas$1.4M
- Harry GreenbergLas Vegas$1.1M
- Miriam BettencourtLas Vegas$772K
- Victoria FarleyLas Vegas$151K
- Curt SamlaskaHenderson$101K
- Laura OstezanReno$27K
- Robert LiebermanHenderson$22K
- Linda WoodsonLas Vegas$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.